RhythmX AI

RhythmX AI is a healthcare technology company focused on advancing precision medicine through a generative AI-native platform. Launched by SAIGroup with a $100 million investment, the company provides clinicians with predictive and prescriptive analytics to enhance clinical decision-making and improve patient outcomes. The platform integrates longitudinal patient data with clinical guidelines to identify care gaps and recommend personalized treatment plans, particularly in primary care and cardiology. By automating administrative tasks and providing real-time insights, RhythmX AI aims to reduce clinician burnout while increasing the quality of care. The company's initial focus includes chronic disease management and oncology, supported by strategic partnerships with major health systems.